Beyond the Quality Label: Understanding the Different Types of Quality in Non-US Equity Investing
Quality investing in developed non-US markets has run into a strong headwind. After more than a decade of durable outperformance, the highest-quality segments of the MSCI EAFE universe lagged sharply over the year ending April 2026, while lower-quality, more cyclical names led the index higher. The reversal was most acute among compounding and franchise businesses, and it reopens a familiar question for allocators: does a single year of weakness signal a structural problem or a cyclical one? Many managers describe their portfolios as high quality, yet those portfolios differ widely in both composition and performance. The reason is that quality is not one factor.